Sanjivani Paranteral Ltd — Important, 15-11-2025: Company Update

Sanjivani Paranteral announced its financial results for the quarter and half-year. For the quarter, revenue from operations dipped 14.5% year-over-year to Rs. 15.5 Cr, with Profit After Tax at Rs. 1.64 Cr, down 28.6%. Injectables revenue grew 2.4% to Rs. 9.29 Cr, while the oral segment faced shipment challenges, declining 35.4% to Rs. 4.99 Cr. Exports formed 81.6% of total revenue. For the half-year, revenue decreased 3.4% to Rs. 33.39 Cr, and Profit After Tax was Rs. 3.37 Cr, down 16.0%. The company plans to expand its product portfolio through R&D investments.